Impact of Social Determinants of Health on Access to Blood and Marrow Transplantation for Acute Myeloid Leukemia
Somya Khare(Oregon Health & Science University), Eneida R. Nemecek(Oregon Health & Science University), Brandon Hayes‐Lattin(Oregon Health & Science University), Ronan Swords(University of Miami), Jessica Leonard(Oregon Health & Science University), Arpita Gandhi(Oregon Health & Science University), Elie Traer(Memorial Sloan Kettering Cancer Center), Gabrielle Meyers(Oregon Health & Science University), Rachel J. Cook(Oregon Health & Science University), Richard T. Maziarz(Oregon Health & Science University), Laura F. Newell(University of Washington), Kelli Goslee(Oregon Health & Science University), Curtis A. Lachowiez(Oregon Health & Science University), Jennifer N. Saultz(Oregon Health & Science University), Amrita Desai(Oregon Health & Science University)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664